These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice. Nakata Y; Kanahara N; Iyo M J Psychopharmacol; 2017 Dec; 31(12):1511-1518. PubMed ID: 28925317 [TBL] [Abstract][Full Text] [Related]
24. Schizophrenia: Basic and Clinical. Coyle JT Adv Neurobiol; 2017; 15():255-280. PubMed ID: 28674984 [TBL] [Abstract][Full Text] [Related]
25. Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes. Kiemes A; Serrano Navacerrada ME; Kim E; Randall K; Simmons C; Rojo Gonzalez L; Petrinovic MM; Lythgoe DJ; Rotaru D; Di Censo D; Hirschler L; Barbier EL; Vernon AC; Stone JM; Davies C; Cash D; Modinos G Schizophr Bull; 2023 May; 49(3):569-580. PubMed ID: 36573631 [TBL] [Abstract][Full Text] [Related]
26. Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophrenia. Perez SM; Boley A; Lodge DJ Transl Psychiatry; 2019 Oct; 9(1):264. PubMed ID: 31636253 [TBL] [Abstract][Full Text] [Related]
27. Cortical localization of dopamine D4 receptors in the rat brain--immunocytochemical study. Wedzony K; Chocyk A; Maćkowiak M; Fijał K; Czyrak A J Physiol Pharmacol; 2000 Jun; 51(2):205-21. PubMed ID: 10898094 [TBL] [Abstract][Full Text] [Related]
28. Hippocampal interneurons are abnormal in schizophrenia. Konradi C; Yang CK; Zimmerman EI; Lohmann KM; Gresch P; Pantazopoulos H; Berretta S; Heckers S Schizophr Res; 2011 Sep; 131(1-3):165-73. PubMed ID: 21745723 [TBL] [Abstract][Full Text] [Related]
29. A lack of GluN2A-containing NMDA receptors confers a vulnerability to redox dysregulation: Consequences on parvalbumin interneurons, and their perineuronal nets. Cardis R; Cabungcal JH; Dwir D; Do KQ; Steullet P Neurobiol Dis; 2018 Jan; 109(Pt A):64-75. PubMed ID: 29024713 [TBL] [Abstract][Full Text] [Related]
30. Role of dopamine D(2) receptors for antipsychotic activity. Ginovart N; Kapur S Handb Exp Pharmacol; 2012; (212):27-52. PubMed ID: 23129327 [TBL] [Abstract][Full Text] [Related]
31. Parvalbumin, but not calretinin, neurons express high levels of α1-containing GABA Równiak M; Kolenkiewicz M; Kozłowska A J Chem Neuroanat; 2017 Dec; 86():41-51. PubMed ID: 28834708 [TBL] [Abstract][Full Text] [Related]
32. [A new pharmacological strategy for schizophrenia: the partial agonists of D2 dopaminergic receptors. The principle characteristics of aripiprazole]. Costentin J Encephale; 2009 Feb; 35(1):66-72. PubMed ID: 19250996 [TBL] [Abstract][Full Text] [Related]
33. Age-dependent loss of parvalbumin-expressing hippocampal interneurons in mice deficient in CHL1, a mental retardation and schizophrenia susceptibility gene. Schmalbach B; Lepsveridze E; Djogo N; Papashvili G; Kuang F; Leshchyns'ka I; Sytnyk V; Nikonenko AG; Dityatev A; Jakovcevski I; Schachner M J Neurochem; 2015 Nov; 135(4):830-44. PubMed ID: 26285062 [TBL] [Abstract][Full Text] [Related]
34. Early Development of Parvalbumin-, Somatostatin-, and Cholecystokinin-Expressing Neurons in Rat Brain following Prenatal Immune Activation and Maternal Iron Deficiency. Boksa P; Zhang Y; Nouel D; Wong A; Wong TP Dev Neurosci; 2016; 38(5):342-353. PubMed ID: 28214898 [TBL] [Abstract][Full Text] [Related]
35. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene. Kimoto S; Zaki MM; Bazmi HH; Lewis DA JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830 [TBL] [Abstract][Full Text] [Related]
36. Energy deficit in parvalbumin neurons leads to circuit dysfunction, impaired sensory gating and social disability. Inan M; Zhao M; Manuszak M; Karakaya C; Rajadhyaksha AM; Pickel VM; Schwartz TH; Goldstein PA; Manfredi G Neurobiol Dis; 2016 Sep; 93():35-46. PubMed ID: 27105708 [TBL] [Abstract][Full Text] [Related]
37. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
38. Chronic Stress Exposure Reduces Parvalbumin Expression in the Rat Hippocampus through an Imbalance of Redox Mechanisms: Restorative Effect of the Antipsychotic Lurasidone. Rossetti AC; Paladini MS; Colombo M; Gruca P; Lason-Tyburkiewicz M; Tota-Glowczyk K; Papp M; Riva MA; Molteni R Int J Neuropsychopharmacol; 2018 Sep; 21(9):883-893. PubMed ID: 29788232 [TBL] [Abstract][Full Text] [Related]
39. Loss of cyclin-dependent kinase 5 from parvalbumin interneurons leads to hyperinhibition, decreased anxiety, and memory impairment. Rudenko A; Seo J; Hu J; Su SC; de Anda FC; Durak O; Ericsson M; Carlén M; Tsai LH J Neurosci; 2015 Feb; 35(6):2372-83. PubMed ID: 25673832 [TBL] [Abstract][Full Text] [Related]
40. Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression. Chung DW; Volk DW; Arion D; Zhang Y; Sampson AR; Lewis DA Am J Psychiatry; 2016 Jan; 173(1):60-8. PubMed ID: 26337038 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]